WinstonWınston
Back
USANA Health Sciences logo

USANA Health Sciences

USNA
31
Household & Personal Products · Consumer Defensive
Price
$13.55
+0.37 (+2.81%)
Market Cap
$250.2M
Winston Score
31
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jul 4, 2026
How the score breaks down
Quality
Mixed
Growth
Weak
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count falling — buybacks

8.7% over 5y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 20.3M (2021) → 18.6M (2026)

Winston Score History

The full picture

USANA Health Sciences makes vitamins, nutritional supplements, and weight management products. Its customers are everyday consumers who want to improve their health, and it sells brands like USANA Essentials and Reset. The company competes in the global dietary supplements industry, which is crowded with both large consumer brands and smaller wellness companies.

USANA sells its products almost entirely through a direct sales model, meaning independent distributors buy and resell the products rather than stores. It operates in roughly 25 markets, with Asia-Pacific — especially China — generating the majority of its revenue. The direct sales model creates loyalty among its distributor network, but it also creates risk: regulatory pressure on direct selling in China has hurt the business before, and continued weakness in that market remains the key challenge the company faces going forward.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

R&D Spend

$0/ year

Declining (-100% vs prior year)

0.0% of revenue

Below sector average (2%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

46.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~7 years

$161M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$161M cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
78.3%
Premium pricing power — 78.3% gross margin
Profit after running costs
Operating Margin
-9.0%
Losing money on operations — -9.0%
Return on the money invested
ROCE
2.3%
Weak — 2.3% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+1.6%
Nearly flat sales (+1.6% YoY)
Profit growth
EPS YoY
-167.1%
Earnings shrinking (-167.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
1.7%
Thin free cash flow (1.7%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
29.98x
Comfortably covers interest (30.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial